Gout News and Research

RSS
Gout is a type of arthritis that causes painful inflammation in the joints. Usually it affects one joint which is most commonly the big toe. However, it can affect any joint in the body such as the ankles, knees, wrists, elbows and any joints in the hands or finger.

Symptoms of gout usually develop rapidly and usually start at night. The joint may then start to feel normal again with any pain or discomfort eventually disappearing . However, most people who get gout will have further attacks in the future.

The symptoms of gout are caused by an above normal level of urate in the bloodstream, which builds up and forms crystals, mainly in and around joints and especially in the finger and toe joints. This can lead to intensely pain and inflammation.

There are several factors that can increase the level of blood urate. These include a diet rich in purines (which form urate when broken down) such as red meat, seafood and some other foods; excess alcohol consumption; the use of certain medicines such as diuretics; a family history of gout; kidney disease; and overweight or obesity.

Gout affects about 1% of the population and is more common in men, particularly those aged 30 to 60, and in women who have already experienced the menopause.
Obesity stigma and yo-yo dieting, not BMI, are behind chronic health conditions, dietitian claims

Obesity stigma and yo-yo dieting, not BMI, are behind chronic health conditions, dietitian claims

Survey says half of people with rheumatoid disease struggle to pay for treatment

Survey says half of people with rheumatoid disease struggle to pay for treatment

Modifiable risk factors play key roles in the development of gout

Modifiable risk factors play key roles in the development of gout

Danish-American researchers find new way to treat chronic inflammation

Danish-American researchers find new way to treat chronic inflammation

Gout patients have higher risk of advanced kidney disease, study finds

Gout patients have higher risk of advanced kidney disease, study finds

Polycystic kidney disease may be preventable

Polycystic kidney disease may be preventable

Fruit fly model for studying diseases like gout, kidney stones reveals new drug targets

Fruit fly model for studying diseases like gout, kidney stones reveals new drug targets

Company expands development plans for drugs which slow progression to dialysis

Company expands development plans for drugs which slow progression to dialysis

Montmorency tart cherry juice may help improve cognitive performance in older adults

Montmorency tart cherry juice may help improve cognitive performance in older adults

Study reports significant link between exposure to inorganic dust and gout in women

Study reports significant link between exposure to inorganic dust and gout in women

Promising methods for early detection and treatment of rheumatoid arthritis

Promising methods for early detection and treatment of rheumatoid arthritis

Immune system discovery may lead to new models for diagnosing inflammatory diseases

Immune system discovery may lead to new models for diagnosing inflammatory diseases

Removing damaged mitochondria may relieve chronic inflammatory conditions

Removing damaged mitochondria may relieve chronic inflammatory conditions

Researchers discover unique approach to treat some chronic inflammatory diseases

Researchers discover unique approach to treat some chronic inflammatory diseases

Gout treatment could potentially reduce complications accompanying metabolic syndrome

Gout treatment could potentially reduce complications accompanying metabolic syndrome

Success for new cholesterol-lowering drug

Success for new cholesterol-lowering drug

Researchers review applications, properties, and pharmacological potentials of rose hip

Researchers review applications, properties, and pharmacological potentials of rose hip

New study solves longstanding mystery in innate immunity

New study solves longstanding mystery in innate immunity

Antidepressant use increased after Brexit vote

Antidepressant use increased after Brexit vote

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint